e-learning
resources
ERJ
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Involvement of eicosanoids and surfactant protein D in extrinsic allergic alveolitis
Higashi A., Higashi N., Tsuburai T., Takeuchi Y., Taniguchi M., Mita H., Saito A., Takatori K., Arimura K., Akiyama K.
Source:
Eur Respir J 2005; 26: 1069-1073
Journal Issue:
December
Disease area:
Airway diseases, Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Higashi A., Higashi N., Tsuburai T., Takeuchi Y., Taniguchi M., Mita H., Saito A., Takatori K., Arimura K., Akiyama K.. Involvement of eicosanoids and surfactant protein D in extrinsic allergic alveolitis. Eur Respir J 2005; 26: 1069-1073
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
Surfactant protein expression at various COPD Gold stages
Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury
Related content which might interest you:
Increased leukotriene and lower prostaglandin E
2
concentrations in induced sputum of patients with eosinophilic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 733s
Year: 2005
Evidence of mast cell activation and leukotriene release after mannitol inhalation
Source: Eur Respir J 2003; 22: 491-496
Year: 2003
Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice
Source: Eur Respir J 2009; 34: 200-208
Year: 2009
Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing
Source: Eur Respir J 2006; 27: 944-950
Year: 2006
Surfactant protein A in chronic extrinsic allergic alveolitis
Source: Eur Respir J 2012; 39: 1543-1544
Year: 2012
Lipid mediators in severe asthma
Source: Eur Respir Mon 2011; 51: 218-235
Year: 2011
Increased urinary leukotriene E4 concentration in patients with eosinophilic pneumonia
Source: Eur Respir J 2008; 32: 437-442
Year: 2008
Prostaglandin E
2
levels are elevated in nasal lavages from asthmatic patients with allergic rhinitis
Source: Eur Respir J 2003; 22: Suppl. 45, 109s
Year: 2003
Prostaglandin E
2
and cysteinyl leukotriene concentrations in sputum supernatant in smoking asthma
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Imbalance of anti-inflammatory (lipoxin A4) and pro-inflammatory (leukotrien B4) arachidonic acid products in exhaled breath condensate of severe refractory asthma.
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Antigen-induced formation of prostaglandin D
2
in mouse asthma model
Source: Eur Respir J 2005; 26: Suppl. 49, 578s
Year: 2005
Prostaglandin D
2
(PGD
2
) and tryptase release into blood after adenosine and methacholine challenges in asthmatic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 670s
Year: 2006
Critical role of cytosolic phospholipase A2? in bronchial mucus hypersecretion in CFTR-deficient mice
Source: Eur Respir J 2010; 36: 1120-1130
Year: 2010
Downregulation of prostaglandin E
2
in bronchial fibroblasts of asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002
Role of leukotrienes in airway inflammation
Source: Annual Congress 2004 - Early management of inflammatory airway diseases - Can we do better?
Year: 2004
Higher expression of lipoxygenase and cyclooxygenase pathways in bronchial than alveolar lavage from allergic asthmatics
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
Imbalance of anti-inflammatory (resolving D1) and pro-inflammatory (leukotrien B4) arachidonic acid products in exhaled breath condensate of severe refractory asthma.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
The early allergic response in small airways of human precision-cut lung slices
Source: Eur Respir J 2003; 21: 1024-1032
Year: 2003
An update on anti-inflammatory endogenous mediators
Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Year: 2005
Quantitative assessment of cysteinyl leukotrienes in human sputum during the allergen-induced asthmatic response and the effect of GSK2190915, a 5-lipoxygenase activating protein (FLAP) inhibitor
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept